Elsevier Launches Core Measures in Mosby’s Nursing Consult

New material to be updated regularly as requirements in the healthcare industry evolve

Atlanta, GA, October. 18, 2012 – Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of Core Measures in the Quality and Safety section of Mosby’s Nursing Consult. Core Measures is in addition to content on CMS Never Events and Medication Safety already available in Nursing Consult.

The Quality and Safety section of Mosby’s Nursing Consult provides nurses with resources to preserve patient safety and implement quality improvement measures. Quality and Safety information is reviewed regularly and updated as nursing evidence and practice evolve. Educators can use the information for in-service staff sessions and librarians can use the updated content to provide research support for a hospital.

Healthcare facilities are required to follow the Core Measures in order to receive Medicare & Medicaid Services (CMS) reimbursement and accreditation by The Joint Commission (TJC). Core Measures serve as a standardized set of evaluation criteria to assess care through recommended treatment, patient education, patient assessment and discharge instructions.

“Nurses play a critical role in ensuring patient safety and managing patient care,” said Barbara Cullen, Vice President, Healthcare e-Learning for Elsevier. “Understanding Core Measures helps nurses understand established benchmarks and standards for treating complex conditions and diseases, reduce complication risks, prevent readmissions and integrate evidence-based nursing practices into their day-to-day activities.”

CMS Never Events offers links to resources such as books, journals, guidelines, patient education, images, and tools for ten healthcare-acquired conditions to assist nurses in preventing situations such as conducting surgery on the wrong patient or at an incorrect site.

Medication Safety provides resources to help nurses minimize the risk of medication errors and improve medication safety. Information is included on pediatric populations and specific classes of drugs to improve patient care.

A webinar with free continuing education credit will be held on Friday, October 19 at 2:00 pm ET. This detailed webinar will cover why Core Measures were created and illustrate the importance of Core Measures in ensuring quality of patient care. Register online for this webinar.

# # #

About Elsevier Clinical Decision Support
Elsevier Clinical Decision Support, a division of Elsevier, the global leader in medical and health information, provides world class information and point-of-care technology solutions that optimize decisions and actions to improve the overall quality, safety and cost-effectiveness of care. The business delivers on this promise through actionable clinical content, care planning and documentation, drug reference and decision support, learning and performance management, and data mining and outcomes analytics solutions for provider, pharmacy and payer organizations.

About Elsevier
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com

Media contact
Christopher Capot
Director, Corporate Relations
+1 212 633 3164